Skip to main content Back to Top

Todd W. Nesbit

Todd W. Nesbit, PharmD, MBA, CPEL, FASHP ([email protected]) serves as chief pharmacy officer for The Johns Hopkins Hospital and vice president for pharmacy services for Johns Hopkins Health System in Baltimore, Maryland. As executive pharmacy leader, he is responsible for directing hospital and health-system practice, research, and education, and implementing system-wide pharmacy services across the continuum. He is the residency program director for the HSPAL residency program at The Johns Hopkins Hospital and has served as preceptor and mentor to pharmacy students and residents for more than 30 years.

Nesbit received his BS in pharmacy degree from Ohio Northern University, his Doctor of Pharmacy degree from The Ohio State University, and his MBA degree in medical services management from Johns Hopkins University. Through positions of increasing responsibility held in diverse hospitals and academic medical centers, he has worked to promote and advance the role of the pharmacist and clinical pharmacy in health systems.

He has extensive experience serving ASHP and state affiliates, including ASHP Forecast Advisory Committee member and chapter author; Pharmacy Competency Assessment Center Advisory Board member and section editor; co-chair of the Maryland Society of Health-System Pharmacy (MSHP) Practice Model Task Force; voting member of the inaugural Pharmacy Practice Model Summit; and delegate to the Pharmacy Stakeholders Conference on MTM Services. Nesbit has been recognized as a Fellow of ASHP and has achieved the status of Certified Pharmacy Executive Leader by the organization. Nesbit received the MSHP W. Arthur Purdum Award for significant contributions to health-system pharmacy.

Meet Todd W. Nesbit

My philosophy begins with the belief that the patient must always be at the center of our individual and collective decision-making. Medication-use systems must be designed to ensure that the needs of our patients are met holistically within and across all care settings for which we are responsible. Meeting these needs necessitates ownership and accountability by all pharmacists and pharmacy technicians alike, to directly manage drug therapy and ensure the safety and quality of medication use. Professional staff should be empowered through credentialing and privileging and engagement in collaborative practice agreements with other professional colleagues, for optimal efficiency and effectiveness. Leveraging the collective expertise of our technicians is critical to extend their scope and impact the care of more patients. We should deploy automation and robotic systems to reduce the burden of repetitive tasks, optimizing the work to be completed by scarce human resources. Robust analytic frameworks are also essential to validate the patient care impact and outcomes that we intend. We should embrace new and evolving approaches for data management and knowledge generation, through expanded use of artificial intelligence and machine learning. It is imperative that we continue to foster a culture of innovation through research, to support new understanding of disease processes and advances in treatment options for our patients such as genetic and cellular therapies. Lastly, it is crucial that we foster supportive and diverse learning environments, to ensure the availability of the future pharmacy workforce that will be needed to care for our patients.